JAMES LEE to Pharmacogenomic Testing
This is a "connection" page, showing publications JAMES LEE has written about Pharmacogenomic Testing.
Connection Strength
0.356
-
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing. Genet Med. 2021 12; 23(12):2335-2341.
Score: 0.176
-
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation. Pharmacogenet Genomics. 2025 Jan 01; 35(1):1-11.
Score: 0.055
-
Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing. Pharmacogenomics. 2022 01; 23(2):85-95.
Score: 0.046
-
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. Clin Pharmacol Ther. 2021 03; 109(3):705-715.
Score: 0.042
-
Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing. Genet Med. 2019 10; 21(10):2255-2263.
Score: 0.038